These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 29343163

  • 21. Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.
    Igra MS, Paling D, Wattjes MP, Connolly DJA, Hoggard N.
    Br J Radiol; 2017 Jun; 90(1074):20160721. PubMed ID: 28362522
    [Abstract] [Full Text] [Related]

  • 22. Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
    Spadaro M, Caldano M, Marnetto F, Lugaresi A, Bertolotto A.
    J Neuroinflammation; 2015 Aug 12; 12():146. PubMed ID: 26259673
    [Abstract] [Full Text] [Related]

  • 23. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT, Kleerekooper I, Lissenberg-Witte BI, de Vos M, Warnke C, Uitdehaag BMJ, Barkhof F, Killestein J, Wattjes MP.
    JAMA Neurol; 2018 Jul 01; 75(7):827-833. PubMed ID: 29532061
    [Abstract] [Full Text] [Related]

  • 24. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.
    Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A.
    Lancet Neurol; 2010 Apr 01; 9(4):438-46. PubMed ID: 20298967
    [Abstract] [Full Text] [Related]

  • 25. Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
    Calvi A, De Riz M, Pietroboni AM, Ghezzi L, Maltese V, Arighi A, Fumagalli GG, Jacini F, Donelli C, Comi G, Galimberti D, Scarpini E.
    Immunotherapy; 2014 Apr 01; 6(1):23-8. PubMed ID: 24341880
    [Abstract] [Full Text] [Related]

  • 26. MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy.
    Phan-Ba R, Lommers E, Tshibanda L, Calay P, Dubois B, Moonen G, Clifford D, Belachew S.
    J Neurol Neurosurg Psychiatry; 2012 Feb 01; 83(2):224-6. PubMed ID: 22013244
    [Abstract] [Full Text] [Related]

  • 27. Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
    Wattjes MP, Verhoeff L, Zentjens W, Killestein J, van Munster ET, Barkhof F, van Eijk JJ.
    J Neurol Neurosurg Psychiatry; 2013 Oct 01; 84(10):1176-7. PubMed ID: 23695498
    [No Abstract] [Full Text] [Related]

  • 28. Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
    Tan LA, Lopes DK.
    J Clin Neurosci; 2015 Oct 01; 22(10):1669-71. PubMed ID: 26115897
    [Abstract] [Full Text] [Related]

  • 29. Minimal supportive treatment in natalizumab-related PML in a MS patient.
    Lalive PH, Bridel C, Ferfoglia RI, Kaiser L, Du Pasquier R, Barkhof F, Haller S.
    J Neurol Neurosurg Psychiatry; 2015 Mar 01; 86(3):354-5. PubMed ID: 24957322
    [No Abstract] [Full Text] [Related]

  • 30. Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
    Prosperini L, de Rossi N, Scarpazza C, Moiola L, Cosottini M, Gerevini S, Capra R, Italian PML study group.
    PLoS One; 2016 Mar 01; 11(12):e0168376. PubMed ID: 27997580
    [Abstract] [Full Text] [Related]

  • 31. Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
    Blinkenberg M, Sellebjerg F, Leffers AM, Madsen CG, Sørensen PS.
    Mult Scler; 2013 Aug 01; 19(9):1226-9. PubMed ID: 23508652
    [Abstract] [Full Text] [Related]

  • 32. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
    Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D.
    JAMA Neurol; 2013 Mar 01; 70(3):398-402. PubMed ID: 23338729
    [Abstract] [Full Text] [Related]

  • 33. Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort.
    Wijburg MT, Warnke C, Barkhof F, Uitdehaag BMJ, Killestein J, Wattjes MP.
    J Neurol Neurosurg Psychiatry; 2019 Jan 01; 90(1):44-46. PubMed ID: 30100552
    [Abstract] [Full Text] [Related]

  • 34. [A case of subtentorial progressive multifocal leucoencephalopathy in a patient treated with natalizumab].
    Simaniv TO, Ivanova MV, Bryukhov VV, Zakharova MN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019 Jan 01; 119(2. Vyp. 2):98-106. PubMed ID: 31156248
    [Abstract] [Full Text] [Related]

  • 35. Immunological and clinical consequences of treating a patient with natalizumab.
    Schwab N, Höhn KG, Schneider-Hohendorf T, Metz I, Stenner MP, Jilek S, Du Pasquier RA, Gold R, Meuth SG, Ransohoff RM, Brück W, Wiendl H.
    Mult Scler; 2012 Mar 01; 18(3):335-44. PubMed ID: 21908480
    [Abstract] [Full Text] [Related]

  • 36. A rational approach to PML for the clinician.
    Calabrese L.
    Cleve Clin J Med; 2011 Nov 01; 78 Suppl 2():S38-41. PubMed ID: 22123934
    [Abstract] [Full Text] [Related]

  • 37. Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy.
    Kinner M, Prehn C, Schneider R, Schroeder C, Kolb E, Gold R, Hoepner R, Chan A.
    Eur J Neurol; 2021 Mar 01; 28(3):921-927. PubMed ID: 33085811
    [Abstract] [Full Text] [Related]

  • 38. Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
    Pitarokoili K, Hellwig K, Lukas C, Gold R.
    Mult Scler; 2017 Mar 01; 23(3):483-486. PubMed ID: 28260421
    [Abstract] [Full Text] [Related]

  • 39. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis.
    Sahraian MA, Radue EW, Eshaghi A, Besliu S, Minagar A.
    Eur J Neurol; 2012 Aug 01; 19(8):1060-9. PubMed ID: 22136455
    [Abstract] [Full Text] [Related]

  • 40. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K, Yamamoto F, Homma S, Okada Y, Nakamichi K, Saijo M, Tamaoka A.
    BMC Neurol; 2019 Oct 31; 19(1):263. PubMed ID: 31672142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.